Vascular anastomosis is a fundamental technique in revascularization procedures, playing a pivotal role in restoring blood flow and promoting tissue repair. However, the occurrence of intimal hyperplasia (IH) at the anastomotic site often leads to restenosis, which significantly compromises long-term vascular patency and negatively impacts clinical outcomes and patient prognosis1,2. IH is closely associated with intraoperative vascular injury, characterized by abnormal proliferation and migration of smooth muscle cells (SMCs) and excessive deposition of extracellular matrix1. These complex and interrelated pathological processes underline the critical need to elucidate the precise mechanisms of IH to inform preventive and interventional strategies against restenosis.
Due to their reproducibility and precise control, murine models of femoral artery anastomosis have been widely adopted in research on vascular repair and associated pathological mechanisms3,4,5. End-to-end anastomosis in mice allows accurate simulation of post-surgical anastomotic injury, enabling dynamic observation of IH and vascular remodeling. These models provide an ideal platform to study interactions between endothelial cells and SMCs post-surgery and to evaluate the role of inflammatory responses in IH development6. By combining histological analysis and molecular biomarker detection, researchers can comprehensively identify key drivers of IH, offering critical insights into its underlying mechanisms and potential therapeutic targets.
The development of IH is driven by multiple factors, with hemodynamic changes being a critical contributor1,7,8. At the anastomotic site, regions of low shear stress and abnormal oscillatory shear index (OSI) are primary stimuli for SMCs proliferation and migration1,7. Furthermore, compliance mismatches and turbulent blood flow around the anastomosis exacerbate endothelial injury, accelerating IH progression8. These findings underscore the necessity of optimizing surgical techniques and selecting appropriate materials to mitigate pathological changes at the anastomotic site.
In recent years, drug-coated balloons (DCBs) have demonstrated efficacy in reducing IH. Anti-proliferative agents, such as paclitaxel, effectively inhibit SMCs proliferation and migration, significantly reducing the incidence of restenosis9. However, challenges persist in high-flow systems like arteriovenous grafts, where rapid fluctuations in shear stress and high blood flow rates may diminish the efficacy of DCBs1. Future studies should focus on improving the applicability of DCBs in varied hemodynamic environments while leveraging advancements in biomaterials science to develop more personalized and effective solutions for post-surgical restenosis. In addition to localized interventions, systemic factors such as diabetes, atherosclerosis, and endothelial dysfunction significantly influence IH development10. Therefore, clinical strategies should prioritize comprehensive management of these systemic conditions to enhance overall vascular health. Concurrently, the identification and monitoring of novel biomarkers for IH progression could provide opportunities for early intervention. The integration of artificial intelligence into surgical planning offers another promising avenue, allowing for the computational design of optimized anastomotic configurations, thereby improving surgical success rates and prolonging vascular patency.
In the study of post-surgical IH and associated pathological mechanisms, the femoral artery anastomosis model stands out for its precision and reproducibility11. This model, employing microsurgical techniques to create end-to-end anastomosis of the femoral artery in mice, accurately mimics localized surgical trauma at the anastomotic site. The advantages of this model become particularly evident when compared to models such as wire-induced injury or other alternatives. A major technical advantage of the femoral artery anastomosis model is its ability to induce highly localized and controlled vascular injury12. The surgical trauma allows for a focused impact on the anastomotic region, closely mimicking the injury patterns encountered in clinical vascular surgery. In contrast, wire-induced injury models, while simpler in technique, often result in extensive endothelial denudation, making it difficult to replicate localized trauma observed in real-life anastomotic surgeries13. Furthermore, the variability in the depth and extent of wire-induced damage across different trials potentially diminishes the reproducibility of results. The extensive and diffuse nature of the damage in wire injury models makes it less relevant for investigating the localized IH that is specifically associated with anastomotic regions.
In this study, utilizing a murine model of femoral artery anastomosis, we systematically refined surgical techniques to enhance model success rates and ensure long-term patency of the anastomotic site. Leveraging this established foundation, our study delved into the molecular and cellular mechanisms underlying IH, including regulatory pathways that govern SMCs migration and proliferation, as well as the role of inflammatory mediators in the progression of IH. Through this research, we aim to contribute novel theoretical insights into the mechanisms of post-anastomotic restenosis and establish an experimental foundation for the development of therapeutic strategies specifically targeting IH.